Delivery Order SPE2DB22D2005-SPE2DB23FJPB4

Award Date 5/10/23
Potential Completion Date 5/11/23
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,055.98 firm fixed-price delivery order is for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, with a period of performance through January 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,003.20, is a firm fixed-price delivery order for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a comprehensive range of medical products to federal agencies, particularly within...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,274.71 firm-fixed-price delivery order is for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, with a completion date of June 9, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare...
This federal contract award, valued at $2,884.47, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, with a completion date of December 6, 2023. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
This federal contract award is for the delivery of Loryna 3 mg-0.02 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,168.41, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,775.06 Firm Fixed Price Delivery Order contract is for the supply of 4562888476 LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of November 24, 2023 and was awarded on November 22, 2023. This award is associated with a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product "LORYNA 3 MG-0.02 MG TABLET 28S." The contract award, valued at $1,298.40, has an ultimate completion date of April 1, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor. The $1,373.88 firm-fixed-price delivery order is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a contraceptive medication. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 11, 2024. This award is likely part of a larger Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FL7C6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $4,077.49, is a Firm Fixed Price Delivery Order for the supply of pharmaceutical products, including the drug LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 30, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
The federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,875.38 firm fixed-price delivery order is for the drug product LORYNA 3 MG-0.02 MG TABLET 28S, with a completion date of November 10, 2022. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB23FJPB4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,962.15 firm-fixed-price delivery order is for the pharmaceutical product LORYNA 3 MG-0.02 MG Tablet 28S. The contract has an ultimate completion date of May 11, 2023.

Amerisourcebergen Drug Corp is the prime contractor and holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded through full and open competition without any set-aside designations.

Generated 5/9/25, 10:21 AM